Vella, A.; D’Aversa, E.; Api, M.; Breveglieri, G.; Allegri, M.; Giacomazzi, A.; Marinelli Busilacchi, E.; Fabrizzi, B.; Cestari, T.; Sorio, C.;
et al. mTOR and STAT3 Pathway Hyper-Activation is Associated with Elevated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment. Cancers 2020, 12, 597.
https://doi.org/10.3390/cancers12030597
AMA Style
Vella A, D’Aversa E, Api M, Breveglieri G, Allegri M, Giacomazzi A, Marinelli Busilacchi E, Fabrizzi B, Cestari T, Sorio C,
et al. mTOR and STAT3 Pathway Hyper-Activation is Associated with Elevated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment. Cancers. 2020; 12(3):597.
https://doi.org/10.3390/cancers12030597
Chicago/Turabian Style
Vella, Antonio, Elisabetta D’Aversa, Martina Api, Giulia Breveglieri, Marisole Allegri, Alice Giacomazzi, Elena Marinelli Busilacchi, Benedetta Fabrizzi, Tiziana Cestari, Claudio Sorio,
and et al. 2020. "mTOR and STAT3 Pathway Hyper-Activation is Associated with Elevated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment" Cancers 12, no. 3: 597.
https://doi.org/10.3390/cancers12030597
APA Style
Vella, A., D’Aversa, E., Api, M., Breveglieri, G., Allegri, M., Giacomazzi, A., Marinelli Busilacchi, E., Fabrizzi, B., Cestari, T., Sorio, C., Bedini, G., D’Amico, G., Bronte, V., Poloni, A., Benedetti, A., Bovo, C., Corey, S. J., Borgatti, M., Cipolli, M.,
& Bezzerri, V.
(2020). mTOR and STAT3 Pathway Hyper-Activation is Associated with Elevated Interleukin-6 Levels in Patients with Shwachman-Diamond Syndrome: Further Evidence of Lymphoid Lineage Impairment. Cancers, 12(3), 597.
https://doi.org/10.3390/cancers12030597